logo

For the Inventor, By the Inventor

Brooklyn, NY, United States of America

Jonathan D Rosen

This inventor holds 5 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Banyu Pharmaceutical Co. Ltd. Active years: 2003-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan D Rosen. Retrieved from https://idiyas.com/inventor/jonathan-d-rosen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Brooklyn, NY (US) (2003 - 2011)
  • Iowa City, IA (US) (2010 - 2011)

Company Filing History:

goldMedal4 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal2 out of 4,770 
 
Merck + Co., Inc.
 patents
bronzeMedal1 out of 237 
 
Banyu Pharmaceutical Co. Ltd
 patents
where one patent can have more than one assignee

Years Active: 2003-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 7915407 - Process for {3-[2(R)-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid (2011-03-29),
2. 7902376 - Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates (2011-03-08),
3. 7807829 - [object Object] (2010-10-05),
4. 7718796 - Process for the preparation of caprolactam CGRP antagonist (2010-05-18),
5. 6538134 - 4-Benzyl-2-hydroxy-1,4-oxazine-3-one and polymorphic forms thereof (2003-03-25),

Title: Innovations and Contributions of Jonathan D. Rosen

Introduction

Jonathan D. Rosen is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work primarily focuses on the development of compounds that have therapeutic applications.

Latest Patents

One of his latest patents is a process for the preparation of the compound {3-[2(R)-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid. This invention is particularly relevant as it serves as a substance P (neurokinin-1) receptor antagonist, which can be useful in treating emesis and inflammatory diseases. Another significant patent involves a novel process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates. These compounds are essential in the synthesis of dipeptidyl peptidase-IV inhibitors, which are used in the treatment of Type 2 diabetes.

Career Highlights

Throughout his career, Jonathan has worked with prominent companies such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Jonathan has collaborated with several professionals in his field, including James M. McNamara and Louis Matty. These collaborations have further enhanced his work and the impact of his inventions.

Conclusion

Jonathan D. Rosen's innovative contributions to pharmaceutical science demonstrate his commitment to advancing medical treatments. His patents reflect a deep understanding of complex chemical processes and their applications in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…